These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 31930241)
21. Non-invasive Macrophage Tracking Using Novel Porphysome Nanoparticles in the Post-myocardial Infarction Murine Heart. Ni NC; Jin CS; Cui L; Shao Z; Wu J; Li SH; Weisel RD; Zheng G; Li RK Mol Imaging Biol; 2016 Aug; 18(4):557-68. PubMed ID: 26728161 [TBL] [Abstract][Full Text] [Related]
22. Effects of different natriuretic peptides on nitric oxide synthesis in macrophages. Kiemer AK; Vollmar AM Endocrinology; 1997 Oct; 138(10):4282-90. PubMed ID: 9322941 [TBL] [Abstract][Full Text] [Related]
23. Promoting the Delivery of Nanoparticles to Atherosclerotic Plaques by DNA Coating. Zhang L; Tian XY; Chan CKW; Bai Q; Cheng CK; Chen FM; Cheung MSH; Yin B; Yang H; Yung WY; Chen Z; Ding F; Leung KC; Zhang C; Huang Y; Lau JYW; Choi CHJ ACS Appl Mater Interfaces; 2019 Apr; 11(15):13888-13904. PubMed ID: 30516979 [TBL] [Abstract][Full Text] [Related]
24. STAT6 Upregulation Promotes M2 Macrophage Polarization to Suppress Atherosclerosis. Gong M; Zhuo X; Ma A Med Sci Monit Basic Res; 2017 Jun; 23():240-249. PubMed ID: 28615615 [TBL] [Abstract][Full Text] [Related]
25. Dynamically enhancing plaque targeting via a positive feedback loop using multifunctional biomimetic nanoparticles for plaque regression. Jiang C; Qi Z; He W; Li Z; Tang Y; Wang Y; Huang Y; Zang H; Yang H; Liu J J Control Release; 2019 Aug; 308():71-85. PubMed ID: 31295543 [TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo assessment of heart-homing porous silicon nanoparticles. Ferreira MP; Ranjan S; Correia AM; Mäkilä EM; Kinnunen SM; Zhang H; Shahbazi MA; Almeida PV; Salonen JJ; Ruskoaho HJ; Airaksinen AJ; Hirvonen JT; Santos HA Biomaterials; 2016 Jul; 94():93-104. PubMed ID: 27107168 [TBL] [Abstract][Full Text] [Related]
27. Surface Modification of Polysaccharide-Based Nanoparticles with PEG and Dextran and the Effects on Immune Cell Binding and Stimulatory Characteristics. Bamberger D; Hobernik D; Konhäuser M; Bros M; Wich PR Mol Pharm; 2017 Dec; 14(12):4403-4416. PubMed ID: 29063757 [TBL] [Abstract][Full Text] [Related]
28. Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells. Song Y; Tang C; Yin C Biomaterials; 2018 Dec; 185():117-132. PubMed ID: 30241030 [TBL] [Abstract][Full Text] [Related]
30. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy. Lale SV; R G A; Aravind A; Kumar DS; Koul V Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987 [TBL] [Abstract][Full Text] [Related]
31. Targeting and therapeutic peptides in nanomedicine for atherosclerosis. Chung EJ Exp Biol Med (Maywood); 2016 May; 241(9):891-8. PubMed ID: 27022138 [TBL] [Abstract][Full Text] [Related]
32. Appearance of atrial natriuretic peptide in the ventricles in patients with myocardial infarction. Jougasaki M; Yasue H; Mukoyama M; Nakao K; Takahashi K Am Heart J; 1990 Jan; 119(1):92-6. PubMed ID: 2136966 [TBL] [Abstract][Full Text] [Related]
33. Effects of Protein Corona on Active and Passive Targeting of Cyclic RGD Peptide-Functionalized PEGylation Nanoparticles. Su G; Jiang H; Xu B; Yu Y; Chen X Mol Pharm; 2018 Nov; 15(11):5019-5030. PubMed ID: 30222356 [TBL] [Abstract][Full Text] [Related]
34. Dextran-based therapeutic nanoparticles for hepatic drug delivery. Foerster F; Bamberger D; Schupp J; Weilbächer M; Kaps L; Strobl S; Radi L; Diken M; Strand D; Tuettenberg A; Wich PR; Schuppan D Nanomedicine (Lond); 2016 Oct; 11(20):2663-2677. PubMed ID: 27628057 [TBL] [Abstract][Full Text] [Related]
35. Carboxyl- and amino-functionalized polystyrene nanoparticles differentially affect the polarization profile of M1 and M2 macrophage subsets. Fuchs AK; Syrovets T; Haas KA; Loos C; Musyanovych A; Mailänder V; Landfester K; Simmet T Biomaterials; 2016 Apr; 85():78-87. PubMed ID: 26854393 [TBL] [Abstract][Full Text] [Related]
36. EMC10 (Endoplasmic Reticulum Membrane Protein Complex Subunit 10) Is a Bone Marrow-Derived Angiogenic Growth Factor Promoting Tissue Repair After Myocardial Infarction. Reboll MR; Korf-Klingebiel M; Klede S; Polten F; Brinkmann E; Reimann I; Schönfeld HJ; Bobadilla M; Faix J; Kensah G; Gruh I; Klintschar M; Gaestel M; Niessen HW; Pich A; Bauersachs J; Gogos JA; Wang Y; Wollert KC Circulation; 2017 Nov; 136(19):1809-1823. PubMed ID: 28931551 [TBL] [Abstract][Full Text] [Related]
37. Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression. Rahman K; Vengrenyuk Y; Ramsey SA; Vila NR; Girgis NM; Liu J; Gusarova V; Gromada J; Weinstock A; Moore KJ; Loke P; Fisher EA J Clin Invest; 2017 Aug; 127(8):2904-2915. PubMed ID: 28650342 [TBL] [Abstract][Full Text] [Related]
38. A core-shell structure QRu-PLGA-RES-DS NP nanocomposite with photothermal response-induced M2 macrophage polarization for rheumatoid arthritis therapy. Chen X; Zhu X; Ma L; Lin A; Gong Y; Yuan G; Liu J Nanoscale; 2019 Oct; 11(39):18209-18223. PubMed ID: 31560010 [TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinase-12 produced by Ly6C Kubota A; Suto A; Suzuki K; Kobayashi Y; Nakajima H J Mol Cell Cardiol; 2019 Jun; 131():41-52. PubMed ID: 31009606 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages. Ngambenjawong C; Cieslewicz M; Schellinger JG; Pun SH J Control Release; 2016 Feb; 224():103-111. PubMed ID: 26772876 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]